A Novel Small Molecule Targets NKCC1 To Restore Synaptic Inhibition.

Raveendran, Vineeth A; Pressey, Jessica C; Woodin, Melanie A

Raveendran, Vineeth A; Pressey, Jessica C; Woodin, Melanie A.

Afiliación

Raveendran VA; Department of Cell and Systems Biology, University of Toronto, Toronto, ON M5S 3G5, Canada.
Pressey JC; Department of Cell and Systems Biology, University of Toronto, Toronto, ON M5S 3G5, Canada.
Woodin MA; Department of Cell and Systems Biology, University of Toronto, Toronto, ON M5S 3G5, Canada. Electronic address: m.woodin@utoronto.ca.

Trends Pharmacol Sci ; 41(12): 897-899, 2020 12.

Article en En | MEDLINE | ID: mdl-33097285

Palabras clave

Down syndrome; NKCC1; autism; excitationinhibition balance; in silico, drug discovery

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Trends Pharmacol Sci Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google